Development and validation of a contrast-enhanced CT-based radiomics nomogram for differentiating mass-like thymic hyperplasia and low-risk thymoma.

MLA

Dong, Wentao, et al. “Development and Validation of a Contrast-Enhanced CT-Based Radiomics Nomogram for Differentiating Mass-like Thymic Hyperplasia and Low-Risk Thymoma.” Journal of Cancer Research and Clinical Oncology, vol. 149, no. 16, Nov. 2023, pp. 14901–10. EBSCOhost, https://doi.org/10.1007/s00432-023-05263-3.

APA

Dong, W., Xiong, S., Wang, X., Hu, S., Liu, Y., Liu, H., Wang, X., Chen, J., Qiu, Y., & Fan, B. (2023). Development and validation of a contrast-enhanced CT-based radiomics nomogram for differentiating mass-like thymic hyperplasia and low-risk thymoma. Journal of Cancer Research and Clinical Oncology, 149(16), 14901–14910. https://doi.org/10.1007/s00432-023-05263-3

Chicago

Dong, Wentao, Situ Xiong, Xiaolian Wang, Shaobo Hu, Yangchun Liu, Hao Liu, Xin Wang, Jiaqi Chen, Yingying Qiu, and Bing Fan. 2023. “Development and Validation of a Contrast-Enhanced CT-Based Radiomics Nomogram for Differentiating Mass-like Thymic Hyperplasia and Low-Risk Thymoma.” Journal of Cancer Research and Clinical Oncology 149 (16): 14901–10. doi:10.1007/s00432-023-05263-3.